Hasanatuludhhiyah, N.; Mustika, A.; Kalanjati, V.P.; Miftahussurur, M.; Uemura, N.
Acetyl-CoA Carboxylase Inhibitors for Nonalcoholic Fatty Liver Disease: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. Pharmaceuticals 2025, 18, 1276.
https://doi.org/10.3390/ph18091276
AMA Style
Hasanatuludhhiyah N, Mustika A, Kalanjati VP, Miftahussurur M, Uemura N.
Acetyl-CoA Carboxylase Inhibitors for Nonalcoholic Fatty Liver Disease: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. Pharmaceuticals. 2025; 18(9):1276.
https://doi.org/10.3390/ph18091276
Chicago/Turabian Style
Hasanatuludhhiyah, Nurina, Arifa Mustika, Viskasari P. Kalanjati, Muhammad Miftahussurur, and Naoto Uemura.
2025. "Acetyl-CoA Carboxylase Inhibitors for Nonalcoholic Fatty Liver Disease: A Systematic Review and Meta-Analysis of Randomized Controlled Trials" Pharmaceuticals 18, no. 9: 1276.
https://doi.org/10.3390/ph18091276
APA Style
Hasanatuludhhiyah, N., Mustika, A., Kalanjati, V. P., Miftahussurur, M., & Uemura, N.
(2025). Acetyl-CoA Carboxylase Inhibitors for Nonalcoholic Fatty Liver Disease: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. Pharmaceuticals, 18(9), 1276.
https://doi.org/10.3390/ph18091276